Sol H. Weiss, a Shareholder of Anapol Schwartz, is an experienced trial attorney known for his exacting preparation and attention to detail.
Phone: (215) 735-2098
|1710 Spruce Street
Philadelphia, PA 19103
Fax: (215) 875-7701
A “lawyer’s lawyer,” he is able to handle the most complex case and still present the facts and law in a way that the judge and jury will understand.
Mr. Weiss concentrates his practice in complex civil litigation including class actions and pharmaceutical cases, medical and other professional malpractice, securities litigation and products liability matters.
Notable Verdicts and Settlements
- $765 million proposed settlement in NFL concussion litigation
- $3.75 billion settlement in Fen-Phen litigation
- $68.5 million settlement for individual clients in Baycol litigation
- $17.75 million partial settlement in the Luzerne County Kids for Cash
- Co-Lead Counsel in NJ consolidated Vioxx litigation
Presently, Mr. Weiss is Co-Lead Counsel in the National Football League Players’ Concussion Injury Litigation, MDL 2323. He is also among Lead Class Counsel in the infamous Kids for Cash civil rights litigation in the United States District Court for the Middle District of Pennsylvania.
Mr. Weiss has served on the executive committee of the American Association of Justice for four years and has served on its board of governors for the last eight years. In 2009 he received the Harry M. Philo award as the Association’s outstanding trial lawyer for his work on limiting Federal Preemption. In 2011, Mr. Weiss received the David S. Shrager President’s Award. He previously served in various positions for the Pennsylvania Association For Justice, and was a member of the Board of the Philadelphia Trial Lawyers Association. He is a past President of the Eastern Pennsylvania Chapter of the American Board of Trial Advocates. He is a frequent lecturer about class actions, pharmaceutical liability, civil litigation issues, trial skills and technology in the courtroom.
Mr. Weiss is a member of the American, Pennsylvania and Philadelphia Bar Association. Mr. Weiss has been appointed as liaison counsel in numerous mass tort litigations consolidated in the court of Common Pleas for Philadelphia County and in coordinated mass tort matters in New Jersey State Courts. He has also served on steering committees in multidistrict litigations in Federal Courts.
Mr. Weiss is an active member of the Board of Consultors of the Villanova University School of Law. He also served as Director of the Linda Creed Breast Cancer Foundation.
Mr. Weiss was named 2014 Lawyer of the Year for the category of Mass Tort and Class Action Litigation by Philadelphia’s Best Lawyers, and he has been named in The Best Lawyers in America® since 2006. He was featured on the cover of the 2011 edition of Philadelphia’s Best Lawyers®.
Mr. Weiss received the 2011 AAJ David S. Shrager Award. He has been included in Pennsylvania Super Lawyers® every year since 2004 and has been named among the Top 100 Pennsylvania Attorneys and Top 100 Lawyers in Philadelphia since 2010.
Education and Background
Mr. Weiss earned his bachelor’s degree from the Pennsylvania State University in 1968 and his law degree from Villanova University School of Law in 1972. He is licensed to practice in Pennsylvania and is specially admitted to practice in other states.
Attorney News & Publications
Assessing the State of Products Liability Law Post-‘Tincher.’ The Legal Intelligencer, December 2014.
Mr. Weiss was featured on the cover of the 2011 edition of Philadelphia’s Best Lawyers.
Sol Weiss Named To the Reader’s Choice Top Attorneys List 2010. December 2010.
Analysis: Pfizer Appeals Court’s Recognition of New Pharma Cause of Action. Law.com Interviews Sol H. Weiss, August 2010.
Analysis: BP’s Spill Clean-Up Now Shifts to the Lawyers. Reuters Interviews Sol H. Weiss, August 2010.
Dangerous Devices – Consumers should be able to sue, keeping pace with ‘Wyeth.’ The National Law Journal, May 2009.
Wyeth v. Levine: A Monumental Victory for Consumers. The Legal Intelligencer, April 2009.
When can a drug consumer sue? The principle of ‘preemption’ could strengthen FDA. Philly.com, Nov 2008.
Federal Pre-emption: Another Corporate Bailout. The Legal Intelligencer, October 2008.
Drug Suit Preemption: No special treatment. The National Law Journal, May 2008.